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1726-4Visual impairment and mortality: Are they related?In this issue of the Journal of the Chinese Medical Asso-
ciation, we have included an article from the Shihpai Eye
Study. Therein, Kuang et al1 reported the relationship between
visual impairment and 3-year mortality among older people in
the Shihpai area in the city of Taipei. The association between
visual impairment and mortality has been extensively studied
over a lengthy period of time. The Beaver Dam Eye Study at
Beaver Dam, WI, USA reported that poorer survival was
associated with more severe cataracts and visual impairment in
1995.2 A later follow-up study showed that cataracts, diabetic
retinopathy, and visual impairment were associated with
poorer survival during a 14-year period in 2006.3 The Salis-
bury Eye Evaluation Project in Salisbury, MD, USA described
how worse baseline acuity was associated with a higher
mortality rate in a prospective 8-year cohort in 2005.4 They
reported a similar association in 2014, and also observed that a
decline in visual acuity over time was associated with
increased mortality risk.5 The Blue Mountains Eye Study in
Sydney, Australia reported that age-related cataracts and vis-
ual impairment were associated with increased mortality in
older people in 2001,6 and then described the association
between cataracts and age-related macular degeneration with
higher mortality rate, although the association with visual
impairment could not be verified in 2007.7 In 2009, they
reported that visual impairment predicted mortality in a 13-
year period.8 These long-term epidemiological studies have
shown an association between visual impairment and
increased mortality, with a variety of possible mechanisms.
1. Age, the major risk factor for death
Age is the most important and powerful determinant of
mortality in humans. Most of the referenced epidemiological
studies have adjusted a variety of confounding factors,
including age. Nevertheless, visual impairment seems to
remain significantly associated with higher mortality even
after adjusting for age. There are a number of age-related eye
diseases, such as cataracts, glaucoma, and age-related macular
degeneration. The prevalence and severity of these eye dis-
eases usually increase with age, although possibly at different
speeds. They may represent a biological marker for aging, and
coexist with those changes associated with aging in other vital
organs such as the heart or brain, which are important life span
factors.x.doi.org/10.1016/j.jcma.2014.09.007
901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Ass2. Systemic disease involving the eye and vital organs
Diabetes mellitus is a typical systemic disease affecting
both the eye and multiple vital organs. In a population-based
study with a type 1 diabetic patient cohort, poor control of
blood sugar was found to be associated with diabetic retin-
opathy severity and blindness.9 In this study, it was found that
mortality was higher in patients who had become blind in a
25-year period. This association may reflect the clinical
manifestation of the same disease process in the eye and other
vital organs, which results in blindness and death, respectively.
3. Visual impairment may lead to more accidents
Visual impairment may be associated with an increased
likelihood of accidents, with falls being the most noticeable
event.10,11 The risk factors for falls include aging, gait dis-
order, postural stability, neurological and cardiovascular dis-
orders, medications, environmental factors, and visual
impairment.10 Visual input is important for a person to
maintain balance and prevent falls. Various changes in visual
characters such as far vision, near vision, visual field, binoc-
ular vision, and stereopsis may increase the risk of falls. Visual
impairment may result in an increased likelihood of falls,10,11
with potentially serious consequences such as hip fracture.
More importantly, falls are known to be a leading cause of
mortality among older people.10,11 The Shihpai Eye Study has
included the history of falls as a risk factor for mortality in
their analysis.
4. Visual impairment may cause psychological change
Visual impairment may cause a variety of psychological
changes such as social isolation, cognitive impairment, and
depression.12 Zheng et al12 studied the role of mental well-
being on the mortality rate among visually impaired people.
They found that visual impairment adversely affected mental
wellbeing in adults. Furthermore, it may increase the mortality
risk indirectly through its adverse impact on mental wellbeing.
In the Salisbury Eye Evaluation Project, they also investigated
this question using a questionnaire [General Health Ques-
tionnaire (GHQ-28)] to evaluate depressive symptoms.4
Although they confirmed the association between poor vis-
ual acuity and higher mortality rate, depressive symptomsociation. All rights reserved.
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Study also addresses this point using the Geriatric Depression
Scale-Short Form (GDS-S) to evaluate the extent of depression
present in Taiwan's older population.15. Visual impairment may decrease daily functional status
For any patient, worse vision may cause daily activities to
become increasingly difficult; it has been shown that func-
tional status is correlated with patient mortality rate. The
functional status of daily activity was assessed in two cate-
gories: (1) activities of daily living (ADL), such as bathing,
dressing, eatingdessentially those fundamental functions in
daily life; and (2) instrumental ADL (IADL), such as tele-
phone use, shopping, and houseworkdthose functions nec-
essary for an individual to live independently in the
community.5 Previous studies have shown that visual impair-
ment was associated with an increased risk of mortality indi-
rectly through the associated declines in IADL levels, but not
in ADL levels.5,136. If patient vision is somehow improved, will the mor-
tality risk decrease accordingly?
In the Salisbury Eye Evaluation Project in 2005, research-
ers found that women who lost three lines of visual acuity over
a 2-year period had an elevated risk of mortality.4 By contrast,
those people who recovered two or more lines of visual acuity
over 2 years had a lower risk of mortality.4 In the Blue
Mountains Eye Study in 2013,14 participants who had both
cataracts and visual impairment were compared with those
who had undergone cataract surgery at 5- and 10-year follow
ups. After adjusting for age, sex, and a number of other
covariates, participants who received cataract surgery and no
longer had visual impairment had significantly lower long-
term mortality risk than those who had not undergone cata-
ract surgery.14 Thus, surgical correction of cataract-induced
visual impairment in older persons may help not only to
improve their quality of life, but also to increase long-term
survival. The manifest strength of the Shihpai Eye Study is
that it is a population-based, large-scale prospective study.
Most importantly, it has included a comprehensive set of risk
variables such as depression and falls for risk adjustment.1Conflicts of interest
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